QL
PACB icon

Quarry LP’s Pacific Biosciences PACB Stock Holding History

Quarry LP’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$847 Buy
+504
New +$733 ﹤0.01% 2031
2024
Q2 		– Sell
-106,985
Closed -$401K – 2024
2024
Q1 		$401K Buy
+106,985
New +$626K 0.08% 158

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quarry LP's PACB Position: Q2 2026 in Review

Quarry LP opened a new position in Pacific Biosciences (PACB) in Q2 2026: 504 shares worth $847. The stake represents ﹤0.01% of the portfolio and ranks #2031 among its holdings. This is a return to the name: Quarry LP previously reported a position in PACB as recently as Q1 2024.

Quarry LP first reported a position in PACB in Q1 2024 and has held it in 2 quarters since. The position peaked at $401K in Q1 2024. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Quarry LP held 504 shares of Pacific Biosciences worth $847 as of Q2 2026.
  • Pacific Biosciences was a new Quarry LP position in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2031 holding.
  • Quarry LP first reported a position in Pacific Biosciences in Q1 2024 and has held it in 2 quarters since.
  • Quarry LP's Pacific Biosciences position peaked at $401K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.